(Q33371011)

English

Cutaneous, pulmonary and hepatic sarcoidosis associated with autoimmune complications during interferon-alpha treatment for hepatitis C virus infection

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Cutaneous, pulmonary and hepatic sarcoidosis associated with autoimmune complications during interferon-alpha treatment for hepatitis C virus infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

author name string

B N Akay

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

P Ekmekci

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

H Sanli

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

G Celik

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

M Bozdayi

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

1 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Journal of the European Academy of Dermatology and Venereology

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

442-445

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Etiology of sarcoidosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01450.X

21 January 2018

Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01450.X

21 January 2018

Sarcoidosis induced by interferon therapy for chronic myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01450.X

21 January 2018

[Pulmonal sarcoidosis: A rare side effect of interferon-alpha treatment for chronic hepatitis C infection]

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01450.X

21 January 2018

Side effects of high-dose interferon therapy for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01450.X

21 January 2018

Treatment of autoimmune and extrahepatic manifestations of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01450.X

21 January 2018

Strong association of hepatitis C virus (HCV) infection and thrombocytopenia: implications from a survey of a community with hyperendemic HCV infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01450.X

21 January 2018

Possible autoimmune thrombocytopenia associated with pegylated interferon-alpha2a plus ribavarin treatment for hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01450.X

21 January 2018

Management of hepatitis C virus-related arthritis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01450.X

21 January 2018

Sarcoidosis-associated hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01450.X

21 January 2018

Identifiers

10.1111/J.1468-3083.2006.01450.X

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33371011&oldid=1536572029"